Login to Your Account



IPO ‘March’ continues; Scynexis, Igntya file; Aquinox, Recro set terms

By Jennifer Boggs
Managing Editor

Tuesday, March 4, 2014
Two more biopharmas joined the initial public offering (IPO) queue late last week – Scynexis Inc. aiming to raise up to $55 million for its fungal infection pipeline and cancer firm Ignyta Inc. filing to raise up to $40 million – and, after two quiet weeks on the IPO front, two firms are expected to make their debuts this week.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription